These C57BL/6J-congenic Ifngr1 Ifnar1 double mutant animals harbor knockout alleles of the receptors for interferon-γ and interferon-α/β. When homozygous for each allele, the double knockout mice exhibit a reduced immune response and increased susceptibility to infectious agents. These mice may be useful in studying antiviral immune responses, as well as interferon stimulation. Mouse mutants involving these genes have been used in studies of Zika virus pathogenesis.Read More +
|Allele Type||Gene Symbol||Gene Name|
|Targeted (Null/Knockout)||Ifngr1||interferon gamma receptor 1|
|Allele Type||Gene Symbol||Gene Name|
|Targeted (Null/Knockout)||Ifnar1||interferon (alpha and beta) receptor 1|
These C57BL/6J-congenic Ifngr1 Ifnar1 double mutant animals harbor null alleles of the receptors for interferon-γ and interferon-α/β. The phenotype of each individual mutation is described below. When homozygous for each null allele, the Ifngr1 Ifnar1 double knockout mice (Ifngr1 Ifnar1 dKO) may have even greater susceptibility to certain infections/agents. These mice may be useful in studying antiviral immune responses, as well as interferon stimulation. Mouse mutants involving these genes have been used in studies of Zika virus pathogenesis.
Ifngr1 encodes the ligand-binding chain (alpha) of the heterodimeric IFN-γ receptor (found on macrophages). Ifnar1 encodes the type-I interferon-α/β receptor (type-I IFN receptor). Binding of their ligands (type-II IFN and type-I IFN, respectively) activates JAK-STAT signaling pathways critical for regulating growth, survival, differentiation, pathogen resistance and antiviral immune responses.
The Ifngr1 null allele (Stock No. 003288), often referred to as 'G129' when maintained on a 129 genetic background, encodes a non-functional protein lacking the cytoplasmic domain needed for signaling. Mice singly homozygous for this null allele (Ifngr1-/-) have normal T cell responses but are defective in natural resistance, evidenced by an increased susceptibility to infection by Listeria monocytogenes and vaccinia virus. Homozygotes are viable and fertile with the immune deficiencies described above.
The Ifnar1 null allele (from Stock No. 028288) has exon 3 deleted; resulting in a non-functional protein (the exon 2-4 splice variant and frameshift leads to translation of 11 arbitrary (missense) amino acids within the N-terminal extracellular domain followed by a stop codon). Mice singly homozygous for this null allele (Ifnar1-/-) lack type-I IFN receptor function; leading to reduced immune response and increased susceptibility to viral infection. For example, in response to Pneumocystis lung infection, Ifnar1-/- animals develop a transient bone marrow crisis largely due to loss of neutrophils. Homozygous null mice are viable and fertile, with the immune deficiencies described above. Heterozygous mice are viable and fertile with no reported abnormalities.
Similar to other immunodeficient strains, maintaining Ifnar1-/- mice in high health status (specific pathogen-free) vivaria promotes overall colony health. If homozygous null animals are maintained in low health barrier rooms, the use of medicated water (e.g., sulfatrim/trimethoprim-sulfa or enrofloxacin/Baytril) is suggested to increase overall colony health.
The C57BL/6J-congenic Ifngr1 Ifnar1 double mutant animals were created in 2016 by breeding mice harboring the Ifngr1 null allele (Stock No. 003288) with mice harboring the Ifnar1 null allele (Stock No. 028288). Each null allele is described below.
The Ifngr1 null targeted mutation (Ifngr1tm1Agt; often called 'G129' when on a 129 genetic background) was designed by Dr. Michel Aguet (University of Zurich). This has a neomycin cassette inserted into exon V (encoding an extracellular membrane-proximal portion of the receptor) of the interferon-γ receptor 1 locus (Ifngr1) on chromosome 10. C57BL/6J-congenic (N10) mice harboring the Ifngr1 null allele (Stock No. 003288) were used for creating the Ifngr1 Ifnar1 double mutant animals.
The Ifnar1 null allele (Ifnar1tm1.2Ees) was designed by Dr. Edward E. Schmidt (Montana State University) to have a deletion of exon 3 of the type-I interferon-α/β receptor locus (Ifnar1) on chromosome 16. C57BL/6J-congenic (N5) mice harboring the Ifngar1 null allele (Stock No. 028288) were used for creating the Ifngr1 Ifnar1 double mutant animals.
|Allele Name||targeted mutation 1, Michel Aguet|
|Allele Type||Targeted (Null/Knockout)|
|Allele Synonym(s)||Ifngr1tm1Agt; targeted mutation 1, Michel Aguet|
|Gene Symbol and Name||Ifngr1, interferon gamma receptor 1|
|Gene Synonym(s)||Ifgr; IFN-gammaR; IMD27B; Nktar; Ifgr; IFN-gamma R; IFNGR; IMD27A; CD119; Ifngr|
|Strain of Origin||129S7/SvEvBrd-Hprt+|
|Molecular Note||Insertion of a neomycin cassette into exon V, which encodes an extracellular membrane-proximal portion of the receptor.|
|Mutations Made By|| |
Dr. Michel Aguet, EPFL, Ecole polytechnique fédérale de Lausanne
|Allele Name||targeted mutation 1.2, Edward E Schmidt|
|Allele Type||Targeted (Null/Knockout)|
|Allele Synonym(s)||targeted mutation 1.2, Edward E Schmidt; Ifnar1tm1.2Ees|
|Gene Symbol and Name||Ifnar1, interferon (alpha and beta) receptor 1|
|Gene Synonym(s)||AVP; Ifar; Ifrc; Ifar; IFN-alpha-REC; IFN-alpha/betaR; IFNAR; IFNBR; IFRC; Ifrc|
|Strain of Origin||(C57BL/6 x 129S6/SvEvTac)F1|
|Molecular Note||The targeting vector was designed to insert a self-excising FRT-Prm1pFlppol2Neo-FRT cassette and loxP site in intron 2, and a second loxP site in intron 3 of the gene. Facilitated self-excision of the cassette in the male germline and resulted in offspring with one FRT site and loxP site upstream of exon 3, and a second loxP site downstream of exon 3. Cre-mediated recombination removed the floxed neo cassette and exon 3. The resulting non-functional protein contains an exon 2-4 splice variant and frameshift leading to translation of 11 arbitrary (missense) amino acids within the N-terminal extracellular domain followed by a stop codon.|
When maintaining a live colony, mice homozygous for both null alleles (Ifngr1 Ifnar1 dKO) may be bred together.
Mice homozygous for both null alleles (Ifngr1 Ifnar1 dKO) are viable and fertile but immunodeficient. As such, and similar to other immunodeficient strains, maintaining Ifngr1 Ifnar1 dKO mice in high health status (specific pathogen-free) vivaria promotes overall colony health. If Ifngr1 Ifnar1 dKO animals are maintained in low health barrier rooms, the use of medicated water (e.g., sulfatrim/trimethoprim-sulfa or enrofloxacin/Baytril) is suggested to increase overall colony health.
When using the Ifngr1 Ifnar1 double knockout mouse strain in a publication, please cite the originating article(s) and include JAX stock #029098 in your Materials and Methods section.
|Heterozygous Ifngr1<tm1Agt> and Ifnar1<tm1.2Ees>|
We will fulfill your order by providing at least two carriers for each strain ordered. The total number, sex, and genotypes provided will vary, although typically 8 or more animals are provided. Please check genotypes which will be recovered. While the genotypes of all animals produced will be communicated to you prior to scheduling shipment, the genotypes of animals provided may not reflect the mating scheme and genotypes described in the strain description. Animals are typically ready to ship in 11-14 weeks. If a second recovery is required to produce the minimum number of animals, then delivery time would increase to approximately 25 weeks. If we fail to produce animals of the correct genotype, you will not be charged. We cannot guarantee the reproductive success of mice shipped to your facility. If the mice are lost after the first three days (post-arrival) or do not produce progeny at your facility, a new order and fee will be necessary.
Cryorecovery to establish a Dedicated Supply for greater quantities of mice. Mice recovered can be used to establish a dedicated colony to contractually supply you mice according to your requirements. Price by quotation.
"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCT(S)" means biological materials supplied by JACKSON, and their derivatives. "SERVICES" means projects conducted by JACKSON for other parties that may include but are not limited to the use of MICE or PRODUCTS. "RECIPIENT" means each recipient of MICE, PRODUCTS, or SERVICES provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE, PRODUCTS or SERVICES from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON’s prior written authorization.
MICE, PRODUCTS AND SERVICES ARE PROVIDED "AS IS". JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of, PRODUCTS or SERVICES, JACKSON will, at its option, provide credit or replacement for the PRODUCT received or the SERVICES provided; JACKSON makes no other representations and this shall be the exclusive remedy of the purchaser. Please note specific policy for live mice.
Consistent with the requirement for a written understanding regarding animal care and use, the JACKSON Animal Care and Use Committee will review the animal care and use protocol(s) associated with any SERVICES to be performed at JACKSON, and JACKSON shall have ultimate responsibility and authority for the care of animals while on site or in JACKSON custody.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS, or SERVICES, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS, or SERVICES from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE, PRODUCTS or SERVICES are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or SERVICES. In addition, special terms and conditions of sale of certain MICE, PRODUCTS, or SERVICES may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and SERVICES by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or SERVICES shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or SERVICES by JACKSON.